Stockhub

Medigene AG: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

17 August 2022

  • curprev 07:5307:53, 17 August 2022 >Paris 1,036 bytes +1,036 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Medigene AG, a biotechnology company, focuses on the development of T cell immunotherapies for the treatment of cancer. The company is developing personalized T cell-based therapies with a focus on T cell receptor-modified T cells in the areas of unmet medical needs, which are in clinical development. It also focuses on dendritic cell vaccines and T cell-specific monoclonal antibodies. In addition, the company focuses on de..."
Retrieved from "https://stockhub.co/research/Medigene_AG"